手机扫码访问本站
微信咨询
Background: |
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin-protein ligases. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein is required for the destruction of mitotic cyclins and for cell cycle progression, and may be involved in cancer progression. Multiple transcript variants encoding different isoforms have been found for this gene. Pseudogenes of this gene have been defined on chromosomes 4, 14, 15, 18, and 19. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
UBE2C |
Immunogen: |
Full length fusion protein |
Full name: |
ubiquitin conjugating enzyme E2C |
Synonyms: |
UBCH10; dJ447F3.2 |
SwissProt: |
O00762 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human thyroid cancer |
IHC Recommend dilution: |
25-100 |
WB Predicted band size: |
20 kDa |
WB Positive control: |
231,Hela and HT-29 cell lysates |
WB Recommended dilution: |
200-1000 |